[Treatment of coronary circulatory disorders].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects; D006801:Humans; D009928:Organ Specificity; D014665:Vasodilator Agents / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D014665:Vasodilator Agents
Zur Behandlung koronarer Durchblutungsstörungen.